[1]
Gold, L.S., Del Rosso, J., Kircik, L., Bhatia, N.D., Hooper, D., Nahm, W. and Stuart, I. 2020. Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s91. DOI:https://doi.org/10.25251/skin.4.supp.91.